The aim of this study is to investigate facial nerve outcomes after microsurgical resection in neurofibromatosis type 2 (NF2) compared to sporadic tumors.
Study Design
Single institutional retrospective chart review.
Setting
Tertiary referral center.
Methods
All adult patients with NF2 vestibular schwannoma (VS) or sporadic VS who underwent microsurgical resection from 2008 to 2019 with preoperative magnetic resonance imaging (MRI) and 1 year of postsurgical follow-up were included. The primary outcome measure was postoperative House-Brackmann (HB) facial nerve score measured at first postoperative visit and after at least 10 months.
Results
In total, 161 sporadic VSs and 14 NF2 VSs met inclusion criteria. Both median tumor diameter (NF2, 33.5 mm vs sporadic, 24 mm, P = .0011) and median tumor volume (NF2, 12.4 cm3 vs sporadic, 2.9 cm3, P = .0005) were significantly greater in patients with NF2. The median follow-up was 24.9 months (range, 12-130.1). Median facial nerve function after 1 year for patients with NF2 was HB 3 (range, 1-6) compared to HB 1 (range, 1-6) for sporadic VS (P = .001). With multivariate logistic regression, NF2 tumors (odds ratio [OR] = 13.9, P = .001) and tumor volume ≥3 cm3 (OR = 3.6, P = .025) were significantly associated with HB ≥3 when controlling for age, sex, extent of tumor resection, translabyrinthine approach, and prior radiation.
Conclusion
Tumor volume >3 cm3 and NF2 tumors are associated with poorer facial nerve outcomes 1 year following microsurgical resection.
KaulVCosettiMK.Management of vestibular schwannoma (including NF2): facial nerve considerations. Otolaryngol Clin North Am. 2018;51(6):1193-1212.
2.
KshettryVRHsiehJKOstromQTKruchkoCBarnholtz-SloanJS.Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015;124(2):223-228.
3.
MarinelliJPLohseCMCarlsonML.Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg. 2018;159(4):717-723.
4.
PenaIChewEYLandauBPBreenJTZevallosJPVrabecJT.Diagnostic criteria for detection of vestibular schwannomas in the VA population. Otol Neurotol. 2016;37(10):1510-1515.
5.
CarlsonMLHabermannEBWagieAE, et al. The changing landscape of vestibular schwannoma management in the United States—a shift toward conservatism. Otolaryngol Head Neck Surg. 2015;153(3):440-446.
6.
FoleyRWShiraziSMaweniRM, et al. Signs and symptoms of acoustic neuroma at initial presentation: an exploratory analysis. Cureus. 2017;9(11):e1846.
GinzkeyCScheichMHarnischW, et al. Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach. Eur Arch Otorhinolaryngol. 2013;270(4):1209-1216.
9.
MeyerTACantyPAWilkinsonEPHansenMRRubinsteinJTGantzBJ.Small acoustic neuromas: surgical outcomes versus observation or radiation. Otol Neurotol. 2006;27(3):380-392.
10.
CollettiVFiorinoF.Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol. 2003;24(6):927-934.
11.
GurgelRKDogruSAmdurRLMonfaredA.Facial nerve outcomes after surgery for large vestibular schwannomas: do surgical approach and extent of resection matter?Neurosurg Focus. 2012;33(3):E16.
RahimpourSFriedmanAHFukushimaTZomorodiAR.Microsurgical resection of vestibular schwannomas: complication avoidance. J Neurooncol. 2016;130(2):367-375.
14.
FoleyRW.Acoustic neuroma quality of life: are we missing the point?Eur Arch Otorhinolaryngol. 2019;276(5):1549-1550.
15.
SamiiMGerganovVSamiiA.Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg. 2006;105(4):527-535.
16.
da CruzMJMoffatDAHardyDG.Postoperative quality of life in vestibular schwannoma patients measured by the SF36 Health Questionnaire. Laryngoscope. 2000;110(1):151-155.
17.
MartinHCSethiJLangDNeil-DwyerGLutmanMEYardleyL.Patient-assessed outcomes after excision of acoustic neuroma: postoperative symptoms and quality of life. J Neurosurg. 2001;94(2):211-216.
18.
LeeJFungKLownieSPParnesLS.Assessing impairment and disability of facial paralysis in patients with vestibular schwannoma. Arch Otolaryngol Head Neck Surg. 2007;133(1):56-60.
19.
YangISughrueMEHanSJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol. 2009;93(1):41-48.
20.
SamiiMGerganovVMSamiiA.Functional outcome after complete surgical removal of giant vestibular schwannomas. J Neurosurg. 2010;112(4):860-867.
21.
SughrueMEYangIRutkowskiMJArandaDParsaAT.Preservation of facial nerve function after resection of vestibular schwannoma. Br J Neurosurg. 2010;24(6):666-671.
22.
GrahnkeKGarstJRMartinBLeonettiJPAndersonDE.Prognostic indices for predicting facial nerve outcome following the resection of large acoustic neuromas. J Neurol Surg B Skull Base. 2017;78(6):454-460.
23.
KunertPDziedzicTPodgorskaANowakACzernickiTMarchelA.Surgery for sporadic vestibular schwannoma, part IV: predictive factors influencing facial nerve function after surgery. Neurol Neurochir Pol. 2016;50(1):36-44.
24.
MoffatDAParkerRAHardyDGMacfarlaneR.Factors affecting final facial nerve outcome following vestibular schwannoma surgery. J Laryngol Otol. 2014;128(5):406-415.
25.
AhnJRyuNGLimJKangMSeolHJChoYS.Prognostic factors of facial nerve function after vestibular schwannoma removal via translabyrinthine approach. Acta Otolaryngol. 2019;139(6):541-546.
26.
BlochOSughrueMEKaurR, et al. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol. 2011;102(2):281-286.
27.
HallidayJRutherfordSAMcCabeMGEvansDG.An update on the diagnosis and treatment of vestibular schwannoma. Expert Rev Neurother. 2018;18(1):29-39.
28.
OlshanMSrinivasanVMLandrumTSataloffRT.Acoustic neuroma: an investigation of associations between tumor size and diagnostic delays, facial weakness, and surgical complications. Ear Nose Throat J. 2014;93(8):304-316.
29.
SchroederRDAngeloLSKurzrockR.NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget. 2014;5(1):67-77.
30.
ManiakasASalibaI.Neurofibromatosis type 2 vestibular schwannoma treatment: a review of the literature, trends, and outcomes. Otol Neurotol. 2014;35(5):889-894.
31.
TysomeJRMacfarlaneRDurie-GairJ, et al. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2. Otol Neurotol. 2012;33(3):466-472.
32.
YaoLAlahmariMTemelYHovingaK.Therapy of sporadic and NF2-related vestibular schwannoma. Cancers (Basel). 2020;12(4):835.
33.
ZhaoFWangBYangZ, et al. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation. J Neurooncol. 2018;138(2):417-424.
34.
MahboubiHMaducdocMMYauAY, et al. Vestibular schwannoma excision in sporadic versus neurofibromatosis type 2 populations. Otolaryngol Head Neck Surg. 2015;153(5):822-831.
35.
SamiiMMatthiesCTatagibaM.Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery. 1997;40(4):696-705.
36.
HouseJWBrackmannDE.Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146-147.
37.
MoffatDALloydSKMacfarlaneR, et al. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2. Br J Neurosurg. 2013;27(4):446-453.
38.
TroudeLBoucekineMMontavaM, et al. Does NF2 status impact the results of combined surgery and adjunctive Gamma Knife surgery for large vestibular schwannomas?Neurosurg Rev. 2020;43:1191-1199.
39.
EvansDG.Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16.
40.
DohertyJGoJLLinthicumFHJr.Neurofibromatosis 2 invasion of the internal auditory canal wall: clinical significance. Otol Neurotol. 2014;35(9):1662-1668.
41.
LloydSKEvansDG.Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol. 2013;115:957-967.
42.
El-KashlanHKZeitounHArtsHAHoffJTTelianSA.Recurrence of acoustic neuroma after incomplete resection. Am J Otol. 2000;21(3):389-392.
43.
BrackmannDECullenRDFisherLM.Facial nerve function after translabyrinthine vestibular schwannoma surgery. Otolaryngol Head Neck Surg. 2007;136(5):773-777.
44.
FentonJEChinRYFaganPASterkersOSterkersJM.Predictive factors of long-term facial nerve function after vestibular schwannoma surgery. Otol Neurotol. 2002;23(3):388-392.
45.
SpringborgJBFugleholmKPoulsgaardLCaye-ThomasenPThomsenJStangerupSE.Outcome after translabyrinthine surgery for vestibular schwannomas: report on 1244 patients. J Neurol Surg B Skull Base. 2012;73(3):168-174.
46.
TorresRNguyenYVanierA, et al. Multivariate analysis of factors influencing facial nerve outcome following microsurgical resection of vestibular schwannoma. Otolaryngol Head Neck Surg. 2017;156(3):525-533.
47.
MonfaredACorralesCETheodosopoulosPV, et al. Facial nerve outcome and tumor control rate as a function of degree of resection in treatment of large acoustic neuromas: preliminary report of the Acoustic Neuroma Subtotal Resection Study (ANSRS). Neurosurgery. 2016;79(2):194-203.
48.
SharmaMSonigAAmbekarSNandaA.Radiological and clinical factors predicting the facial nerve outcome following retrosigmoid approach for large vestibular schwannomas (VSs). J Neurol Surg B Skull Base. 2013;74(5):317-323.
49.
NakatomiHJacobJTCarlsonML, et al. Long-term risk of recurrence and regrowth after gross-total and subtotal resection of sporadic vestibular schwannoma [published online May 19, 2017]. J Neurosurg.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
